Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity
Research output: Contribution to journal › Article › peer-review
Standard Standard
Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity. / Hughes, D.; Hughes, D.A.; Vilar, F.J. et al.
In: Pharmacogenetics, Vol. 14, No. 6, 01.06.2004, p. 335-342.
In: Pharmacogenetics, Vol. 14, No. 6, 01.06.2004, p. 335-342.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
Hughes, D, Hughes, DA, Vilar, FJ, Ward, CC, Alfirevic, A, Park, BK & Pirmohamed, M 2004, 'Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity', Pharmacogenetics, vol. 14, no. 6, pp. 335-342. https://doi.org/10.1097/00008571-200406000-00002
APA
Hughes, D., Hughes, D. A., Vilar, F. J., Ward, C. C., Alfirevic, A., Park, B. K., & Pirmohamed, M. (2004). Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity. Pharmacogenetics, 14(6), 335-342. https://doi.org/10.1097/00008571-200406000-00002
CBE
Hughes D, Hughes DA, Vilar FJ, Ward CC, Alfirevic A, Park BK, Pirmohamed M. 2004. Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity. Pharmacogenetics. 14(6):335-342. https://doi.org/10.1097/00008571-200406000-00002
MLA
Hughes, D. et al. "Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity". Pharmacogenetics. 2004, 14(6). 335-342. https://doi.org/10.1097/00008571-200406000-00002
VancouverVancouver
Hughes D, Hughes DA, Vilar FJ, Ward CC, Alfirevic A, Park BK et al. Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity. Pharmacogenetics. 2004 Jun 1;14(6):335-342. doi: 10.1097/00008571-200406000-00002
Author
RIS
TY - JOUR
T1 - Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity
AU - Hughes, D.
AU - Hughes, D.A.
AU - Vilar, F.J.
AU - Ward, C.C.
AU - Alfirevic, A.
AU - Park, B.K.
AU - Pirmohamed, M.
PY - 2004/6/1
Y1 - 2004/6/1
KW - BIOTECHNOLOGY & APPLIED MICROBIOLOGY
KW - GENETICS & HEREDITY
KW - PHARMACOLOGY & PHARMACY
U2 - 10.1097/00008571-200406000-00002
DO - 10.1097/00008571-200406000-00002
M3 - Article
VL - 14
SP - 335
EP - 342
JO - Pharmacogenetics
JF - Pharmacogenetics
SN - 0960-314X
IS - 6
ER -